Evidence map›Paper›PMID 20228056›Full record

ArticleThe Journal of biological chemistry2010

Co-regulation of caveolar and Cdc42-dependent fluid phase endocytosis by phosphocaveolin-1.

Zhi-Jie Cheng, Raman Deep Singh, Eileen L Holicky, Christine L Wheatley, David L Marks, Richard E Pagano

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Functional genomics identify causal variant underlying the protective CTSH locus for Alzheimer's disease.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Lung Endothelial Transcytosis.Comprehensive Physiology · 2020
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Clathrin-independent pathways of endocytosis.Cold Spring Harbor perspectives in biology · 2014
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zhi-Jie ChengDepartments of Medicine and Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
Raman Deep SinghDepartments of Medicine and Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
Eileen L HolickyDepartments of Medicine and Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
Christine L WheatleyDepartments of Medicine and Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
David L MarksDepartments of Medicine and Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905.
Richard E PaganoDepartments of Medicine and Biochemistry and Molecular Biology, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, Rochester, Minnesota 55905. Electronic address: pagano.richard@mayo.edu.
Mayo Clinic · US

Funding

INTRACELLULAR TRANSLOCATION AND METABOLISM OF LIPIDSR01GM022942 · NIGMS · MAYO CLINIC ROCHESTER · PI MARKS, DAVID LARRY · 1985 to 2010
$5.3M
Regulation of Glucose Transporter Trafficking by LipidsF32DK068985 · NIDDK · MAYO CLINIC ROCHESTER · PI CHENG, ZHI-JIE · 2005 to 2006
$109k
INTRACELLULAR TRANSLOCATION AND METABOLISM OF LIPIDSR37GM022942 · NIGMS · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI PAGANO, RICHARD E · 1989 to 1998
–
NIDDK NIH HHS F32 DK068985NIDDK NIH HHS F32-DK068985NIGMS NIH HHS GM22942NIGMS NIH HHS R01 GM022942
6 · The paper itself

Abstract

Several clathrin-independent endocytosis mechanisms have been identified that can be distinguished by specific requirements for certain proteins, such as caveolin-1 (Cav1) and the Rho GTPases, RhoA and Cdc42, as well as by specific cargo. Some endocytic pathways may be co-regulated such that disruption of one pathway leads to the up-regulation of another; however, the underlying mechanisms for this are unclear. Cav1 has been reported to function as a guanine nucleotide dissociation inhibitor (GDI), which inhibits Cdc42 activation. We tested the hypothesis that Cav1 can regulate Cdc42-dependent, fluid phase endocytosis. We demonstrate that Cav1 overexpression decreases fluid phase endocytosis, whereas silencing of Cav1 enhances this pathway. Enhancement of Cav1 phosphorylation using a phosphatase inhibitor reduces Cdc42-regulated pinocytosis while stimulating caveolar endocytosis. Fluid phase endocytosis was inhibited by expression of a putative phosphomimetic mutant, Cav1-Y14E, but not by the phospho-deficient mutant, Cav1-Y14F. Overexpression of Cav2, or a Cav1 mutant in which the GDI region was altered to the corresponding sequence in Cav2, did not suppress fluid phase endocytosis. These results suggest that the Cav1 expression level and phosphorylation state regulates fluid phase endocytosis via the interaction between the Cav1 GDI region and Cdc42. These data define a novel molecular mechanism for co-regulation of two distinct clathrin-independent endocytic pathways.

Indexed as

EndocytosisAnimalsCaveolaeCaveolin 1cdc42 GTP-Binding ProteinCHO CellsCricetinaeCricetulusMicroscopy, ElectronMicroscopy, FluorescencePhosphoproteinsCaveolin 1cdc42 GTP-Binding ProteinPhosphoproteins

Identifiers

PMID20228056
PMCPMC2865320
OpenAlexW2004575760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.